Shaji Kumar, M.D.
Mayo Clinic
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Shaji Kumar, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:17 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT03399539 · Venetoclax, Ixazomib Citrate, and Dexamethasone in Treating Patients with Relapsed Multiple MyelomaMayo Clinic · completed · Recurrent Plasma Cell Myeloma, T(11;14) · principal investigator
- Ph2NCT03012880 · Ixazomib Citrate, Lenalidomide, Dexamethasone, and Daratumumab in Treating Patients With Newly Diagnosed Multiple MyelomaMayo Clinic · completed · Plasma Cell Myeloma · principal investigator
- Ph1/Ph2NCT02633059 · Idasanutlin, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple MyelomaMayo Clinic · completed · Loss of Chromosome 17p, Recurrent Plasma Cell Myeloma · principal investigator
- Ph1/Ph2NCT01864018 · Ixazomib With Cyclophosphamide and Dexamethasone in Patients With Previously Untreated Symptomatic Multiple Myeloma or Light Chain AmyloidosisMayo Clinic · completed · Amyloidosis, Plasma Cell Myeloma · principal investigator
- Ph2NCT01078441 · Bortezomib, Liposomal Doxorubicin Hydrochloride, Dexamethasone, and Cyclophosphamide in Treating Patients With Multiple Myeloma That Relapsed After Autologous Stem Cell TransplantNational Cancer Institute (NCI) · terminated · Refractory Multiple Myeloma · study chair
- Ph2NCT01072773 · Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Light Chain AmyloidosisMayo Clinic · completed · Primary Systemic Amyloidosis · study chair
- Ph2NCT00998049 · Plerixafor in Treating Patients With Multiple Myeloma Previously Treated With Lenalidomide and Planning to Undergo Autologous Stem Cell TransplantMayo Clinic · completed · Multiple Myeloma, Refractory Multiple Myeloma, Stage I Multiple Myeloma · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:17 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Eastern Cooperative Oncology Group Operations OfficeU10CA021115 · NCI · FRONTIER SCI & TECHNOLOGY RSCH FDN, INC · PI ROBERT L COMIS · fiscal years 1985 to 2013Named on NCT01078441
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in multiple myeloma.